E. K. Aksoy Et Al. , "Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen," MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6, pp.523-529, 2017
Aksoy, E. K. Et Al. 2017. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen. MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6 , 523-529.
Aksoy, E. K., Sapmaz, F. P., GÖKTAŞ, Z., Uzman, M., & Nazligul, Y., (2017). Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen. MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6, 523-529.
Aksoy, Evrim Et Al. "Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen," MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6, 523-529, 2017
Aksoy, Evrim K. Et Al. "Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen." MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6, pp.523-529, 2017
Aksoy, E. K. Et Al. (2017) . "Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen." MEDICAL PRINCIPLES AND PRACTICE , vol.26, no.6, pp.523-529.
@article{article, author={Evrim Kahramanoglu Aksoy Et Al. }, title={Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen}, journal={MEDICAL PRINCIPLES AND PRACTICE}, year=2017, pages={523-529} }